Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis (Q45122630)

9 December 2017

Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis (English)

1 reference

9 December 2017

0 references

1 reference

ChEBI release 2020-05-28

11

1 reference

9 December 2017

12

1 reference

9 December 2017

Haichao Wang

8

0 references

Christine N. Metz

9

object named as

Christine Metz

1 reference

9 December 2017

3

Mahendar Ochani

1 reference

9 December 2017

5

Xinchun Lin

1 reference

9 December 2017

Hong Wang

1

1 reference

9 December 2017

Hong Liao

2

1 reference

9 December 2017

Marilou Justiniani

4

1 reference

9 December 2017

Lihong Yang

6

1 reference

9 December 2017

Yousef Al-Abed

7

1 reference

9 December 2017

Edmund J Miller

10

1 reference

9 December 2017

language of work or name

English

0 references

publication date

24 October 2004

1 reference

9 December 2017

6

1 reference

inferred from page(s)

published in

Nature Medicine

1 reference

9 December 2017

10

1 reference

9 December 2017

1216-1221

1 reference

9 December 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/nm1124

9 December 2017

0 references

cites work

Epidemiology of sepsis syndrome in 8 academic medical centers

1 reference

7 January 2021

Quality-adjusted survival in the first year after the acute respiratory distress syndrome

1 reference

7 January 2021

Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome

1 reference

7 January 2021

Has the mortality of septic shock changed with time

1 reference

7 January 2021

HMGB1 in the immunology of sepsis (not septic shock) and arthritis

1 reference

7 January 2021

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

1 reference

7 January 2021

Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation

1 reference

7 January 2021

Novel strategies for the treatment of sepsis

1 reference

7 January 2021

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

1 reference

7 January 2021

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group

1 reference

7 January 2021

Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients

1 reference

7 January 2021

HMG-1 as a late mediator of endotoxin lethality in mice

1 reference

7 January 2021

High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes

1 reference

7 January 2021

Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation

1 reference

7 January 2021

At the crossroads of necrosis and apoptosis: signaling to multiple cellular targets by HMGB1.

1 reference

7 January 2021

Reversing established sepsis with antagonists of endogenous high-mobility group box 1.

1 reference

7 January 2021

Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion

1 reference

7 January 2021

Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin

1 reference

7 January 2021

Pharmacological stimulation of the cholinergic antiinflammatory pathway

1 reference

7 January 2021

The inflammatory reflex

1 reference

7 January 2021

Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation

1 reference

7 January 2021

IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism

1 reference

7 January 2021

A protein kinase involved in the regulation of inflammatory cytokine biosynthesis

1 reference

7 January 2021

Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms

1 reference

7 January 2021

Function and activation of NF-kappa B in the immune system

1 reference

7 January 2021

NF-kappaB regulation in the immune system

1 reference

7 January 2021

Lipid unites disparate syndromes of sepsis

1 reference

7 January 2021

Emerging structure of the nicotinic acetylcholine receptors

1 reference

7 January 2021

Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications

1 reference

7 January 2021

Acetylcholine receptor channel imaged in the open state

1 reference

7 January 2021

Nicotinic acetylcholine receptors: from structure to brain function

1 reference

7 January 2021

Transdermal nicotine for ulcerative colitis

1 reference

7 January 2021

Efferent vagal fibre stimulation blunts nuclear factor-kappaB activation and protects against hypovolemic hemorrhagic shock.

1 reference

7 January 2021

High mobility group box chromosomal protein 1 as a nuclear protein, cytokine, and potential therapeutic target in arthritis

1 reference

7 January 2021

HMGB1 is a potent trigger of arthritis

1 reference

7 January 2021

Cigarette Smoking and Ulcerative Colitis

1 reference

7 January 2021

Smoking and ulcerative colitis

1 reference

7 January 2021

MIF mediation of sepsis

1 reference

7 January 2021

Protection from septic shock by neutralization of macrophage migration inhibitory factor

1 reference

7 January 2021

Therapeutic effects of lysophosphatidylcholine in experimental sepsis

1 reference

7 January 2021

Depletion of casein kinase II by antisense oligonucleotide prevents neuritogenesis in neuroblastoma cells.

1 reference

7 January 2021

Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM1124

1 reference

Dimensions Publication ID

9 December 2017

0 references

1 reference